<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36187294</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-5102</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cellular neuroscience</Title><ISOAbbreviation>Front Cell Neurosci</ISOAbbreviation></Journal><ArticleTitle>Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.</ArticleTitle><Pagination><StartPage>977039</StartPage><MedlinePgn>977039</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">977039</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fncel.2022.977039</ELocationID><Abstract><AbstractText>SARS-CoV-2 causes COVID-19, which has claimed millions of lives. This virus can infect various cells and tissues, including the brain, for which numerous neurological symptoms have been reported, ranging from mild and non-life-threatening (e.g., headaches, anosmia, dysgeusia, and disorientation) to severe and life-threatening symptoms (e.g., meningitis, ischemic stroke, and cerebral thrombosis). The cellular receptor for SARS-CoV-2 is angiotensin-converting enzyme 2 (ACE2), an enzyme that belongs to the renin-angiotensin system (RAS). RAS is an endocrine system that has been classically associated with regulating blood pressure and fluid and electrolyte balance; however, it is also involved in promoting inflammation, proliferation, fibrogenesis, and lipogenesis. Two pathways constitute the RAS with counter-balancing effects, which is the key to its regulation. The first axis (classical) is composed of angiotensin-converting enzyme (ACE), angiotensin (Ang) II, and angiotensin type 1 receptor (AT1R) as the main effector, which -when activated- increases the production of aldosterone and antidiuretic hormone, sympathetic nervous system tone, blood pressure, vasoconstriction, fibrosis, inflammation, and reactive oxygen species (ROS) production. Both systemic and local classical RAS' within the brain are associated with cognitive impairment, cell death, and inflammation. The second axis (non-classical or alternative) includes ACE2, which converts Ang II to Ang-(1-7), a peptide molecule that activates Mas receptor (MasR) in charge of opposing Ang II/AT1R actions. Thus, the alternative RAS axis enhances cognition, synaptic remodeling, cell survival, cell signal transmission, and antioxidant/anti-inflammatory mechanisms in the brain. In a physiological state, both RAS axes remain balanced. However, some factors can dysregulate systemic and local RAS arms. The binding of SARS-CoV-2 to ACE2 causes the internalization and degradation of this enzyme, reducing its activity, and disrupting the balance of systemic and local RAS, which partially explain the appearance of some of the neurological symptoms associated with COVID-19. Therefore, this review aims to analyze the role of RAS in the development of the neurological effects due to SARS-CoV-2 infection. Moreover, we will discuss the RAS-molecular targets that could be used for therapeutic purposes to treat the short and long-term neurological COVID-19-related sequelae.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 M&#xe9;ndez-Garc&#xed;a, Escobedo, Minguer-Uribe, Viurcos-Sanabria, Aguayo-Guerrero, Carrillo-Ruiz and Solleiro-Villavicencio.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xe9;ndez-Garc&#xed;a</LastName><ForeName>Luc&#xed;a A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga," Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escobedo</LastName><ForeName>Galileo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga," Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minguer-Uribe</LastName><ForeName>Alan Gerardo</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neuropathology, Cellular Physiology Institute, National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viurcos-Sanabria</LastName><ForeName>Rebeca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga," Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PECEM, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguayo-Guerrero</LastName><ForeName>Jos&#xe9; A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Laboratory of Immunometabolism, Research Division, General Hospital of Mexico "Dr. Eduardo Liceaga," Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo-Ruiz</LastName><ForeName>Jos&#xe9; Dami&#xe1;n</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Research Directorate, General Hospital of Mexico "Dr. Eduardo Liceaga," Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, General Hospital of Mexico "Dr. Eduardo Liceaga," Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Ciencias de la Salud, Universidad An&#xe1;huac, Huixquilucan, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solleiro-Villavicencio</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Posgrado en Ciencias Gen&#xf3;micas, Universidad Aut&#xf3;noma de la Ciudad de M&#xe9;xico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Neurosci</MedlineTA><NlmUniqueID>101477935</NlmUniqueID><ISSNLinking>1662-5102</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neurological manifestations</Keyword><Keyword MajorTopicYN="N">renin-angiotensin system</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36187294</ArticleId><ArticleId IdType="pmc">PMC9523599</ArticleId><ArticleId IdType="doi">10.3389/fncel.2022.977039</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrah&#xe3;o M. V., Dos Santos N. F. T., Kuwabara W. M. T., do Amaral F. G., do Carmo, Buonfiglio D., et al. (2019). Identification of insulin-regulated aminopeptidase (IRAP) in the rat pineal gland and the modulation of melatonin synthesis by angiotensin IV. Brain Res. 1704 40&#x2013;46. 10.1016/j.brainres.2018.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.09.015</ArticleId><ArticleId IdType="pubmed">30222958</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida-Santos A. F., Kangussu L. M., Campagnole-Santos M. J. (2017). The renin-angiotensin system and the neurodegenerative diseases: A brief review. Protein Pept. Lett. 24 841&#x2013;853. 10.2174/0929866524666170822120258</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929866524666170822120258</ArticleId><ArticleId IdType="pubmed">28828974</ArticleId></ArticleIdList></Reference><Reference><Citation>Aly O. M. (2020). Molecular docking reveals the potential of aliskiren, dipyridamole, mopidamol, rosuvastatin, rolitetracycline and metamizole to inhibit COVID-19 virus main protease. ChemRxiv [Preprint]. 10.26434/chemrxiv.12061302.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.26434/chemrxiv.12061302.v1</ArticleId><ArticleId IdType="pmc">PMC9054211</ArticleId><ArticleId IdType="pubmed">35515460</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcos F. S., Puche A. R., Vera T. V. (2020). Controversy regarding ACE inhibitors/ARBs in COVID-19. Revista Espanola Cardiol (English Ed.) 73 516. 10.1016/J.REC.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.REC.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7158842</ArticleId><ArticleId IdType="pubmed">32371022</ArticleId></ArticleIdList></Reference><Reference><Citation>Astuti I., Ysrafil. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. Clin. Res. Rev. 14 407&#x2013;412. 10.1016/j.dsx.2020.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.020</ArticleId><ArticleId IdType="pmc">PMC7165108</ArticleId><ArticleId IdType="pubmed">32335367</ArticleId></ArticleIdList></Reference><Reference><Citation>Badierah R. A., Uversky V. N., Redwan E. M. (2020). Dancing with Trojan horses: An interplay between the extracellular vesicles and viruses. J. Biomol. Struct. Dyn. 39 3034&#x2013;3060. 10.1080/07391102.2020.1756409</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1756409</ArticleId><ArticleId IdType="pubmed">32351170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahat G. (2020). COVID-19 and the renin angiotensin system: Implications for the older adults. J. Nutr. Health Aging 24 699&#x2013;704. 10.1007/s12603-020-1403-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-020-1403-7</ArticleId><ArticleId IdType="pmc">PMC7271637</ArticleId><ArticleId IdType="pubmed">32744564</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A. M., Khaleeq A., Ali U., Syeda H. (2020). Evidence of the COVID-19 Virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 11 995&#x2013;998. 10.1021/ACSCHEMNEURO.0C00122</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ACSCHEMNEURO.0C00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B. M., de Vrij F. M. S., Kushner S. A., Harschnitz O., van Riel D. (2022). The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. 45 358&#x2013;368. 10.1016/j.tins.2022.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocci M., Oudenaarden C., S&#xe0;enz-sard&#xe0; X., Simr&#xe9;n J., Ed&#xe9;n A., Sj&#xf6;lund J., et al. (2021). Infection of brain pericytes underlying neuropathology of covid-19 patients. Int. J. Mol. Sci. 22:11622. 10.3390/IJMS222111622/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS222111622/S1</ArticleId><ArticleId IdType="pmc">PMC8583965</ArticleId><ArticleId IdType="pubmed">34769052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodiga V. L., Bodiga S. (2013). Renin angiotensin system in cognitive function and dementia. Asian J. Neurosci. 2013 1&#x2013;18. 10.1155/2013/102602</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/102602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodro M., Compta Y., S&#xe1;nchez-Valle R. (2021). Presentations and mechanisms of CNS disorders related to COVID-19. Neurol. Neuroimmunol. Neuroinflam. 8:e923. 10.1212/NXI.0000000000000923</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000923</ArticleId><ArticleId IdType="pmc">PMC7808129</ArticleId><ArticleId IdType="pubmed">33310765</ArticleId></ArticleIdList></Reference><Reference><Citation>Bois M. C., Boire N. A., Layman A. J., Aubry M. C., Alexander M. P., Roden A. C., et al. (2021). COVID-19-Associated nonocclusive fibrin microthrombi in the heart. Circulation 143 230&#x2013;243. 10.1161/CIRCULATIONAHA.120.050754</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050754</ArticleId><ArticleId IdType="pmc">PMC7805556</ArticleId><ArticleId IdType="pubmed">33197204</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D. H., Tsukahara T., Weinreb C., Lipovsek M., Van Den Berge K., Gong B., et al. (2020). Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 6 1&#x2013;20. 10.1126/sciadv.abc5801</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinker T., Stopa E., Morrison J., Klinge P. (2014). A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11 1&#x2013;16. 10.1186/2045-8118-11-10/FIGURES/3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-11-10/FIGURES/3</ArticleId><ArticleId IdType="pmc">PMC4016637</ArticleId><ArticleId IdType="pubmed">24817998</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X., Prominski A., Lin Y., Ankenbruck N., Rosenberg J., Chen M., et al. (2020). A neutralizing antibody-conjugated photothermal nanoparticle captures and inactivates SARS-CoV-2. bioRxiv [Preprint]. 10.1101/2020.11.30.404624</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.30.404624</ArticleId><ArticleId IdType="pmc">PMC8646742</ArticleId><ArticleId IdType="pubmed">34761549</ArticleId></ArticleIdList></Reference><Reference><Citation>Campana P., Palaia M. E., Conte M., Cante T., Petraglia L., Femminella G. D., et al. (2022). The elderly at risk: Aldosterone as modulator of the immune response to SARS-CoV-2 infection. GeroScience 44 567&#x2013;572. 10.1007/s11357-021-00481-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00481-4</ArticleId><ArticleId IdType="pmc">PMC8570771</ArticleId><ArticleId IdType="pubmed">34741250</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell D. J. (2014). Clinical relevance of local renin angiotensin systems. Front. Endocrinol. 5:113. 10.3389/FENDO.2014.00113</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2014.00113</ArticleId><ArticleId IdType="pmc">PMC4095645</ArticleId><ArticleId IdType="pubmed">25071727</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M., Rajnik M., Cuomo A., Dulebohn S. C., Di Napoli R. (2022). Features, evaluation, and treatment of coronavirus (COVID-19). Tampa: StatPearls.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell M. C. (2016). Biochemical evaluation of the renin-angiotensin system: The good, bad, and absolute? Am. J. Physiol. Heart Circ. Physiol. 310 H137&#x2013;H152. 10.1152/AJPHEART.00618.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/AJPHEART.00618.2015</ArticleId><ArticleId IdType="pmc">PMC4796631</ArticleId><ArticleId IdType="pubmed">26475588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell M. C. (2019). &#x201c;The Angiotensin-(1-7) Axis: Formation and metabolism pathways,&#x201d; in Angiotensin-(1-7), ed. Santos R. (Cham: Springer; ). 10.1007/978-3-030-22696-1_1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-22696-1_1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell M. C., Marshall A. C., Alzayadneh E. M., Shaltout H. A., Diz D. I. (2014). Update on the angiotensin converting enzyme 2-angiotensin (1-7)-Mas receptor axis: Fetal programing, sex differences, and intracellular pathways. Front. Endocrinol. 4:201. 10.3389/FENDO.2013.00201/XML/NLM</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2013.00201/XML/NLM</ArticleId><ArticleId IdType="pmc">PMC3886117</ArticleId><ArticleId IdType="pubmed">24409169</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan. Lancet 395 507&#x2013;513. 10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S. D., Wu C. L., Lin T. K., Chuang Y. C., Yang D. I. (2012). Renin inhibitor aliskiren exerts neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons. Neurochem. Int. 61 369&#x2013;377. 10.1016/J.NEUINT.2012.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUINT.2012.05.012</ArticleId><ArticleId IdType="pubmed">22609375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q., Yang Y., Gao J. (2020). Infectivity of human coronavirus in the brain. EBioMedicine 56:102799. 10.1016/J.EBIOM.2020.102799</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2020.102799</ArticleId><ArticleId IdType="pmc">PMC7255711</ArticleId><ArticleId IdType="pubmed">32474399</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y., Li Q., Zhang Y., Wen Q., Jianjun Z. (2015). Effects of female sex hormones on expression of the Ang-(1-7)/Mas-R/nNOS pathways in rat brain. Can. J. Physiol. Pharmacol. 93 993&#x2013;998. 10.1139/CJPP-2015-0087</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/CJPP-2015-0087</ArticleId><ArticleId IdType="pubmed">26488668</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosarderelioglu C., Nidadavolu L. S., George C. J., Oh E. S., Bennett D. A., Walston J. D., et al. (2020). Brain renin&#x2013;angiotensin system at the intersect of physical and cognitive frailty. Front. Neurosci. 14:586314. 10.3389/fnins.2020.586314</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.586314</ArticleId><ArticleId IdType="pmc">PMC7561440</ArticleId><ArticleId IdType="pubmed">33117127</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Torres M. K., Bichara C. D. A., de Almeida M., de N., do S., Vallinoto M. C., et al. (2022). The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic. Front. Microbiol. 13:30. 10.3389/FMICB.2022.789882/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMICB.2022.789882/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8870622</ArticleId><ArticleId IdType="pubmed">35222327</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. (2018). Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa. Physiol. Rev. 98 477&#x2013;504. 10.1152/PHYSREV.00039.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/PHYSREV.00039.2016</ArticleId><ArticleId IdType="pmc">PMC5866360</ArticleId><ArticleId IdType="pubmed">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Miletti T. C., Gagnon M., Talbot P. J. (2007). Activation of human monocytes after infection by human coronavirus 229E. Virus Res. 130:228. 10.1016/J.VIRUSRES.2007.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.VIRUSRES.2007.06.016</ArticleId><ArticleId IdType="pmc">PMC7114174</ArticleId><ArticleId IdType="pubmed">17669539</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey J., Alam M. T., Chandra S., Gupta J., Ray U., Srivastava A. K., et al. (2021). Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain. J. Med. Virol. 93 1296&#x2013;1303. 10.1002/JMV.26521</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.26521</ArticleId><ArticleId IdType="pubmed">32964419</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Anjos de Paula R. C., de Maria Frota Vasconcelos T., da Costa F. B. S., de Brito L. A., Torres D. M., Moura A. E. F., et al. (2021). Characterization of Headache in COVID-19: A retrospective multicenter study. Mol. Neurobiol. 58 4487&#x2013;4494. 10.1007/s12035-021-02430-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02430-w</ArticleId><ArticleId IdType="pmc">PMC8148871</ArticleId><ArticleId IdType="pubmed">34036488</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Arif G., Farhat A., Khazaal S., Annweiler C., Kovacic H., Wu Y., et al. (2021). The renin-angiotensin system : A key role in SARS-CoV-2-induced COVID-19. Molecules 26:6945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8622307</ArticleId><ArticleId IdType="pubmed">34834033</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Shennawy L., Hoffmann A. D., Dashzeveg N. K., McAndrews K. M., Mehl P. J., Cornish D., et al. (2022). Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2. Nat. Commun. 13:405. 10.1038/S41467-021-27893-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-021-27893-2</ArticleId><ArticleId IdType="pmc">PMC8776790</ArticleId><ArticleId IdType="pubmed">35058437</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M. A., Wilson M. L., Banks W. A. (2020). In vitro modeling of blood&#x2013;brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS 1 1&#x2013;16. 10.1186/S12987-020-00187-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12987-020-00187-3</ArticleId><ArticleId IdType="pmc">PMC7106666</ArticleId><ArticleId IdType="pubmed">32228633</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M., Fejes Z., S&#xfc;t&#xf5; R., Nagy Z., Sz&#xe9;kely B., P&#xf3;csi M., et al. (2022). Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients. Int. J. Infect. Dis. 115 8&#x2013;16. 10.1016/J.IJID.2021.11.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2021.11.028</ArticleId><ArticleId IdType="pmc">PMC8613979</ArticleId><ArticleId IdType="pubmed">34838959</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajloun Z., Kovacic H., Annweiler C., Wu Y., Cao Z., Sabatier J.-M. (2022). SARS-CoV-2-Induced neurological disorders in symptomatic Covid-19 and long covid patients: Key role of brain renin-angiotensin system. Infect. Disord. Drug Targets 22 1&#x2013;3. 10.2174/1871526522666220406124618</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871526522666220406124618</ArticleId><ArticleId IdType="pubmed">35388764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Karakiulakis G., Roth M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 8:e21. 10.1016/S2213-2600(20)30116-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry M., Ferguson A. V. (2007). The sensory circumventricular organs: Brain targets for circulating signals controlling ingestive behavior. Physiol. Behav. 91 413&#x2013;423. 10.1016/J.PHYSBEH.2007.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PHYSBEH.2007.04.003</ArticleId><ArticleId IdType="pubmed">17531276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi M. C., Tieri P., Ortona E., Ruggieri A. (2020). &#x2018;ACE2 expression and sex disparity in COVID-19&#x2019;. Cell Death Discov. 6:37. 10.1038/s41420-020-0276-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-0276-1</ArticleId><ArticleId IdType="pmc">PMC7248455</ArticleId><ArticleId IdType="pubmed">32499922</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerling J. C., Loewy A. D. (2009). Aldosterone in the brain. Am. J. Physiol. Renal Physiol. 297 F559&#x2013;F576. 10.1152/ajprenal.90399.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.90399.2008</ArticleId><ArticleId IdType="pmc">PMC2739715</ArticleId><ArticleId IdType="pubmed">19261742</ArticleId></ArticleIdList></Reference><Reference><Citation>Glodzik L., Santisteban M. M. (2021). Blood-brain barrier crossing renin-angiotensin system drugs: Considerations for dementia and cognitive decline. Hypertension 78:644. 10.1161/HYPERTENSIONAHA.121.17595</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.121.17595</ArticleId><ArticleId IdType="pmc">PMC9125564</ArticleId><ArticleId IdType="pubmed">34379433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Sanchez E. P., Gomez-Sanchez C. M., Plonczynski M., Gomez-Sanchez C. E. (2010). Aldosterone synthesis in the brain contributes to Dahl salt-sensitive rat hypertension. Exp. Physiol. 95, 120&#x2013;130. 10.1113/EXPPHYSIOL.2009.048900</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EXPPHYSIOL.2009.048900</ArticleId><ArticleId IdType="pmc">PMC3077084</ArticleId><ArticleId IdType="pubmed">19837774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves S. C. A., Bassi B. L. T., Kangussu L. M., Alves D. T., Ramos L. K. S., Fernandes L. F., et al. (2022). Alamandine induces neuroprotection in ischemic stroke models. Curr. Med. Chem. 29 3483&#x2013;3498. 10.2174/0929867329666220204145730</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867329666220204145730</ArticleId><ArticleId IdType="pubmed">35125076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez S. M., Siddik A. B., Su R. C. (2021). Regulated intramembrane proteolysis of ACE2: A potential mechanism contributing to COVID-19 pathogenesis? Front. Immunol. 12:1949. 10.3389/FIMMU.2021.612807/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.612807/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8215698</ArticleId><ArticleId IdType="pubmed">34163462</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobe J. L., Xu D., Sigmund C. D. (2008). An intracellular renin-angiotensin system in neurons: Fact, hypothesis, or fantasy. Physiology 23 187&#x2013;193. 10.1152/physiol.00002.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00002.2008</ArticleId><ArticleId IdType="pmc">PMC2538674</ArticleId><ArticleId IdType="pubmed">18697992</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X., Zhu Y., Hong Y. (2020). Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension: A meta-analysis. Hypertension 76 E13&#x2013;E14. 10.1161/HYPERTENSIONAHA.120.15572</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15572</ArticleId><ArticleId IdType="pubmed">32458694</ArticleId></ArticleIdList></Reference><Reference><Citation>Halder S. K., Milner R. (2020). Mild hypoxia triggers transient blood&#x2013;brain barrier disruption: A fundamental protective role for microglia. Acta Neuropathol. Commun. 1 1&#x2013;13. 10.1186/S40478-020-01051-Z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S40478-020-01051-Z</ArticleId><ArticleId IdType="pmc">PMC7592567</ArticleId><ArticleId IdType="pubmed">33115539</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan B. N., Yoo H. J. (2021). Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J. Neurol. 268 3059&#x2013;3071. 10.1007/s00415-021-10406-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilliard L. M., Sampson A. K., Brown R. D., Denton K. M. (2013). &#x2018;The &#x201c;his and hers&#x201d; of the renin-angiotensin system&#x2019;. Curr. Hypertens. Rep. 15 71&#x2013;79. 10.1007/S11906-012-0319-Y/FIGURES/1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11906-012-0319-Y/FIGURES/1</ArticleId><ArticleId IdType="pubmed">23180053</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosomi N., Nishiyama A., Ban C. R., Naya T., Takahashi T., Kohno M., et al. (2005). Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience 134 225&#x2013;231. 10.1016/J.NEUROSCIENCE.2005.03.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUROSCIENCE.2005.03.054</ArticleId><ArticleId IdType="pubmed">15963646</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsuchou H., Kastin A. J., Mishra P. K., Pan W. (2012). C-reactive protein increases BBB permeability: Implications for obesity and neuroinflammation. Cell. Physiol. Biochem. 30 1109&#x2013;1119. 10.1159/000343302</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343302</ArticleId><ArticleId IdType="pmc">PMC4099000</ArticleId><ArticleId IdType="pubmed">23018453</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo J., Zhao Y., Ren J., Zhou D., Duyvesteyn H. M. E., Ginn H. M., et al. (2020). Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe 28 445.e&#x2013;454.e. 10.1016/j.chom.2020.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.06.010</ArticleId><ArticleId IdType="pmc">PMC7303615</ArticleId><ArticleId IdType="pubmed">32585135</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson L., Eldahshan W., Fagan S. C., Ergul A. (2018). Within the brain: The renin angiotensin system. Int. J. Mol. Sci. 19 1&#x2013;23. 10.3390/ijms19030876</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030876</ArticleId><ArticleId IdType="pmc">PMC5877737</ArticleId><ArticleId IdType="pubmed">29543776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakhmola S., Indari O., Chatterjee S., Jha H. C. (2020). SARS-CoV-2, an underestimated pathogen of the nervous system. SN Compr. Clin. Med. 2:1. 10.1007/S42399-020-00522-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S42399-020-00522-7</ArticleId><ArticleId IdType="pmc">PMC7520376</ArticleId><ArticleId IdType="pubmed">33015550</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins T. A., Mendelsohn F. A. O., Albiston A. L., Chai S. Y. (2007). Angiotensin IV Binding Site&#x2019;, hypertension and hormone mechanisms. Totowa, NJ: Humana Press, 61&#x2013;74. 10.1007/978-1-59259-987-5_4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-59259-987-5_4</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen A., Castro A. W., Ferrett M. T., Martinkova J., Vasilevskaya A., Chadha A. S., et al. (2022). &#x2018;Sex and gender differences in the neurological and neuropsychiatric symptoms of long COVID: A narrative review&#x2019;. Italian J. Gender Specif. Med. 8 18&#x2013;28. 10.1723/3769.37563</Citation><ArticleIdList><ArticleId IdType="doi">10.1723/3769.37563</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T., Yu J. T., Zhu X. C., Zhang Q. Q., Tan M. S., Cao L., et al. (2014). Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway. Br. J. Pharmacol. 171 4222&#x2013;4232. 10.1111/BPH.12770</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/BPH.12770</ArticleId><ArticleId IdType="pmc">PMC4241089</ArticleId><ArticleId IdType="pubmed">24824997</ArticleId></ArticleIdList></Reference><Reference><Citation>John G. R., Lee S. C., Brosnan C. F. (2003). Cytokines: Powerful regulators of glial cell activation. Neuroscientist 9 10&#x2013;22. 10.1177/1073858402239587</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858402239587</ArticleId><ArticleId IdType="pubmed">12580336</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira C., Crespo &#xc2;, Ranjbar S., Ingber J., Parry B., Ravid S., et al. (2021). SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. MedRxiv [Preprint]. 10.1101/2021.03.06.21252796</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.06.21252796</ArticleId><ArticleId IdType="pmc">PMC7987031</ArticleId><ArticleId IdType="pubmed">33758872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabbani N., Olds J. L. (2020). Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk. Mol. Pharmacol. 97 351&#x2013;353. 10.1124/MOLPHARM.120.000014</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/MOLPHARM.120.000014</ArticleId><ArticleId IdType="pmc">PMC7237865</ArticleId><ArticleId IdType="pubmed">32238438</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N., Satta S., Komuro Y., Muthukrishnan S. D., Kakarla V., Guo L., et al. (2021). Flow-mediated susceptibility and molecular response of cerebral endothelia to SARS-CoV-2 infection. Stroke 52 260&#x2013;270. 10.1161/STROKEAHA.120.032764</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032764</ArticleId><ArticleId IdType="pmc">PMC7769899</ArticleId><ArticleId IdType="pubmed">33161843</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamyan V. T. (2021). Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19? Physiol. Rep. 9:e14796. 10.14814/PHY2.14796</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/PHY2.14796</ArticleId><ArticleId IdType="pmc">PMC7941673</ArticleId><ArticleId IdType="pubmed">33687143</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsi V., Marketou M., Maragkoudakis S., Didagelos M., Charalambous G., Parthenakis F., et al. (2020). Blood&#x2013;brain barrier dysfunction: The undervalued frontier of hypertension. J. Hum. Hypertens. 34 682&#x2013;691. 10.1038/s41371-020-0352-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0352-2</ArticleId><ArticleId IdType="pubmed">32424144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik P., Kaushik M., Parveen S., Tabassum H., Parvez S. (2020). Cross-talk between key players in patients with COVID-19 and ischemic stroke: A review on neurobiological insight of the pandemic. Mol. Neurobiol. 57 4921&#x2013;4928. 10.1007/s12035-020-02072-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02072-4</ArticleId><ArticleId IdType="pmc">PMC7434850</ArticleId><ArticleId IdType="pubmed">32813238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehoe P. G., Mulhim N. A., Zetterberg H., Blennow K., Miners J. S. (2019). cerebrospinal fluid changes in the renin-angiotensin system in Alzheimer&#x2019;s Disease. J. Alzheimers Dis. 72 525&#x2013;535. 10.3233/JAD-190721</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190721</ArticleId><ArticleId IdType="pubmed">31594235</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyhanian K., Umeton R. P., Mohit B., Davoudi V., Hajighasemi F., Ghasemi M. (2021). SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J. Neuroimmunol. 350 577436. 10.1016/J.JNEUROIM.2020.577436</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNEUROIM.2020.577436</ArticleId><ArticleId IdType="pmc">PMC7647896</ArticleId><ArticleId IdType="pubmed">33212316</ArticleId></ArticleIdList></Reference><Reference><Citation>Khezri M. R., Ghasemnejad-Berenji M. (2021). Neurological effects of elevated levels of angiotensin II in COVID-19 patients. Hum. Cell 34 1941&#x2013;1942. 10.1007/s13577-021-00605-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-021-00605-0</ArticleId><ArticleId IdType="pmc">PMC8395377</ArticleId><ArticleId IdType="pubmed">34449020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow C. S., Zaidi S. T. R., Hasan S. S. (2020). Cardiovascular disease and use of renin-angiotensin system inhibitors in COVID-19. Am. J. Cardiovasc. Drugs 20 217&#x2013;221. 10.1007/S40256-020-00406-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S40256-020-00406-0</ArticleId><ArticleId IdType="pmc">PMC7152511</ArticleId><ArticleId IdType="pubmed">32281055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni P. G., Sakharkar A., Banerjee T. (2022). Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients. Hypertens. Res. 45 254&#x2013;269. 10.1038/S41440-021-00800-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41440-021-00800-4</ArticleId><ArticleId IdType="pmc">PMC8630198</ArticleId><ArticleId IdType="pubmed">34848886</ArticleId></ArticleIdList></Reference><Reference><Citation>Labandeira-Garcia J. L., Rodr&#xed;guez-Perez A. I., Garrido-Gil P., Rodriguez-Pallares J., Lanciego J. L., Guerra M. J. (2017). Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration. Front. Aging Neurosci. 9:129. 10.3389/fnagi.2017.00129</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00129</ArticleId><ArticleId IdType="pmc">PMC5413566</ArticleId><ArticleId IdType="pubmed">28515690</ArticleId></ArticleIdList></Reference><Reference><Citation>Labandeira-Garcia J. L., Valenzuela R., Costa-Besada M. A., Villar-Cheda B., Rodriguez-Perez A. I. (2021). The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons. Prog. Neurobiol. 199:101919. 10.1016/j.pneurobio.2020.101919</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101919</ArticleId><ArticleId IdType="pmc">PMC7543790</ArticleId><ArticleId IdType="pubmed">33039415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamptey J., Oyelami F. O., Owusu M., Nkrumah B., Idowu P. O., Adu-Gyamfi E. A., et al. (2021). Genomic and epidemiological characteristics of SARS-CoV-2 in Africa. PLoS Negl. Trop. Dis. 15:e0009335. 10.1371/JOURNAL.PNTD.0009335</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PNTD.0009335</ArticleId><ArticleId IdType="pmc">PMC8101992</ArticleId><ArticleId IdType="pubmed">33901167</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecl&#xe9;zio A., Robinson J., Banerjee I. (2020). SARS-CoV-2: ACE inhibitors, disastrous or desirable? J. Biomed. Sci. 7 40&#x2013;46. 10.3126/JBS.V7I1.29852</Citation><ArticleIdList><ArticleId IdType="doi">10.3126/JBS.V7I1.29852</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M. M., Docherty K., Sattar N., Mehta N., Kalra A., Nowacki A. S., et al. (2022). Renin&#x2013;angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: Systematic review and meta-analysis. Eur. Heart J. Cardiovasc. Pharmacother. 8 165&#x2013;178. 10.1093/ehjcvp/pvaa138</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcvp/pvaa138</ArticleId><ArticleId IdType="pmc">PMC7799280</ArticleId><ArticleId IdType="pubmed">33337478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Kang B.-M., Kim J. H., Min J., Kim H. S., Ryu H., et al. (2018). Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood-brain barrier permeability in chronically stressed mice. Sci. Rep. 8:13064. 10.1038/s41598-018-30875-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-30875-y</ArticleId><ArticleId IdType="pmc">PMC6117335</ArticleId><ArticleId IdType="pubmed">30166586</ArticleId></ArticleIdList></Reference><Reference><Citation>Libbey J. E., Fujinami R. S. (2011). Neurotropic viral infections leading to epilepsy: Focus on Theiler&#x2019;s murine encephalomyelitis virus. Future Virol. 6:1339. 10.2217/FVL.11.107</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/FVL.11.107</ArticleId><ArticleId IdType="pmc">PMC3259611</ArticleId><ArticleId IdType="pubmed">22267964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lochhead J. J., Kellohen K. L., Ronaldson P. T., Davis T. P. (2019). Distribution of insulin in trigeminal nerve and brain after intranasal administration. Sci. Rep. 1 1&#x2013;9. 10.1038/s41598-019-39191-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39191-5</ArticleId><ArticleId IdType="pmc">PMC6385374</ArticleId><ArticleId IdType="pubmed">30796294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M., Liang J., Liang J., Li H., Yang P. (2021). The effects of the renin inhibitor aliskiren on neuronal toxic damage. Pharmazie 76 544&#x2013;550. 10.1691/PH.2021.1729</Citation><ArticleIdList><ArticleId IdType="doi">10.1691/PH.2021.1729</ArticleId><ArticleId IdType="pubmed">34782039</ArticleId></ArticleIdList></Reference><Reference><Citation>Luissint A. C., Artus C., Glacial F., Ganeshamoorthy K., Couraud P. O. (2012). Tight junctions at the blood brain barrier: Physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 9:23. 10.1186/2045-8118-9-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-9-23</ArticleId><ArticleId IdType="pmc">PMC3542074</ArticleId><ArticleId IdType="pubmed">23140302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W. J., Pogue A., Hill J. M. (2022). SARS-CoV-2 infectivity and neurological targets in the brain. Cell. Mol. Neurobiol. 42 217&#x2013;224. 10.1007/s10571-020-00947-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00947-7</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H., Han L., Xu J. (2020). Apelin/APJ system: A novel promising target for neurodegenerative diseases. J. Cell Physiol. 235 638&#x2013;657. 10.1002/JCP.29001</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JCP.29001</ArticleId><ArticleId IdType="pubmed">31254280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyoo K. S., Kim H. M., Lee B., Che Y. H., Kim S. J., Song D., et al. (2022). Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients. Emerg. Microb. Infect. 11 406&#x2013;411. 10.1080/22221751.2021.2024095</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2024095</ArticleId><ArticleId IdType="pmc">PMC8803065</ArticleId><ArticleId IdType="pubmed">34962444</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. (2020). Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan. China. JAMA Neurol. 77:1. 10.1001/JAMANEUROL.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANEUROL.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidaninikjeh S., Sabouni N., Marzouni H. Z., Bengar S., Khalili A., Jafari R. (2021). Monocytes and macrophages in COVID-19: Friends and foes. Life Sci. 269:11901. 10.1016/j.lfs.2020.119010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.119010</ArticleId><ArticleId IdType="pmc">PMC7834345</ArticleId><ArticleId IdType="pubmed">33454368</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., et al. (2020). Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2 168&#x2013;175. 10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesias V. S. D., Zhu H., Tang X., Dai X., Guo Y., Liu W., et al. (2021). Effective ACE2 peptide-nanoparticle conjugation and its binding with the SARS-Cov-2 RBD quantified by dynamic light scattering. Chem. Commun. 57 6979&#x2013;6982. 10.1039/D1CC02267A</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1CC02267A</ArticleId><ArticleId IdType="pubmed">34190246</ArticleId></ArticleIdList></Reference><Reference><Citation>Messerli F. H., Bangalore S., Bavishi C., Rimoldi S. F. (2018). Angiotensin-converting enzyme inhibitors in hypertension: To use or not to use? J. Am. College Cardiol. 71 1474&#x2013;1482. 10.1016/J.JACC.2018.01.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACC.2018.01.058</ArticleId><ArticleId IdType="pubmed">29598869</ArticleId></ArticleIdList></Reference><Reference><Citation>Momoniat T., Ilyas D., Bhandari S. (2019). ACE inhibitors and ARBs: Managing potassium and renal function. Cleveland Clin. J. Med. 86 601&#x2013;607. 10.3949/CCJM.86A.18024</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/CCJM.86A.18024</ArticleId><ArticleId IdType="pubmed">31498767</ArticleId></ArticleIdList></Reference><Reference><Citation>Montecucco F., Pende A., MacH F. (2009). The renin-angiotensin system modulates inflammatory processes in atherosclerosis: Evidence from basic research and clinical studies. Mediators Inflamm. 2009:752406. 10.1155/2009/752406</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2009/752406</ArticleId><ArticleId IdType="pmc">PMC2668935</ArticleId><ArticleId IdType="pubmed">19390623</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray E., Tomaszewski M., Guzik T. J. (2021). Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: Clinical implications. Cardiovasc. Res. 116 E87&#x2013;E89. 10.1093/CVR/CVAA096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CVR/CVAA096</ArticleId><ArticleId IdType="pmc">PMC7184453</ArticleId><ArticleId IdType="pubmed">32301968</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa P., Sigmund C. D. (2017). &#x2018;How is the brain renin&#x2013;angiotensin system regulated?&#x2019;. Hypertension 70 10&#x2013;18. 10.1161/HYPERTENSIONAHA.117.08550</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.08550</ArticleId><ArticleId IdType="pmc">PMC5511499</ArticleId><ArticleId IdType="pubmed">28559391</ArticleId></ArticleIdList></Reference><Reference><Citation>Naser M., Naser M., Naser M. M., Shehata L. H. (2022). miRNAs and COVID-19 Therapy Review. Int. J. Prog. Sci. Technol. 30 404&#x2013;415. 10.52155/ijpsat.v30.2.4058</Citation><ArticleIdList><ArticleId IdType="doi">10.52155/ijpsat.v30.2.4058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitina E., Larionova I., Choinzonov E., Kzhyshkowska J. (2018). Monocytes and macrophages as viral targets and reservoirs. Int. J. Mol. Sci. 19:2821. 10.3390/IJMS19092821</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS19092821</ArticleId><ArticleId IdType="pmc">PMC6163364</ArticleId><ArticleId IdType="pubmed">30231586</ArticleId></ArticleIdList></Reference><Reference><Citation>Noureddine F. Y., Altara R., Fan F., Yabluchanskiy A., Booz G. W., Zouein F. A. (2020). Impact of the renin&#x2013;angiotensin system on the endothelium in vascular dementia: Unresolved issues and future perspectives. Int. J. Mol. Sci. 21 1&#x2013;14. 10.3390/IJMS21124268</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS21124268</ArticleId><ArticleId IdType="pmc">PMC7349348</ArticleId><ArticleId IdType="pubmed">32560034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouri-Vaskeh M., Kalami N., Zand R., Soroureddin Z., Varshochi M., Ansarin K., et al. (2021). Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial. Int. J. Clin. Practice 75:e14124. 10.1111/IJCP.14124</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/IJCP.14124</ArticleId><ArticleId IdType="pmc">PMC7995089</ArticleId><ArticleId IdType="pubmed">33650197</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien J., Hayder H., Zayed Y., Peng C. (2018). Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. 9:402. 10.3389/FENDO.2018.00402/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FENDO.2018.00402/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi S.-Y., Ball S. (2009). ACE inhibitors: Their properties and current role in hypertension. Prescriber 20 15&#x2013;28. 10.1002/PSB.538</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/PSB.538</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman I. O., Melenotte C., Brouqui P., Million M., Lagier J. C., Parola P., et al. (2021). Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients. Front. Immunol. 12:2350. 10.3389/FIMMU.2021.625732/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.625732/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8236950</ArticleId><ArticleId IdType="pubmed">34194422</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Herrero M., Soto-Rojas L. O., Harrington C. R., Flores-Martinez Y. M., Villegas-Rojas M. M., Le&#xf3;n-Aguilar A. M., et al. (2021). Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection. Front. Neurol. 12:444. 10.3389/FNEUR.2021.660087</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2021.660087</ArticleId><ArticleId IdType="pmc">PMC8072392</ArticleId><ArticleId IdType="pubmed">33912129</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W., Xiang S., Tu H., Kastin A. J. (2007). Cytokines interact with the blood-brain barrier. Weinheim: Wiley-VCH, 247&#x2013;264. 10.1002/9783527611225.CH11</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9783527611225.CH11</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasher A. (2021). COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgr. Med. J. 97 312&#x2013;320. 10.1136/POSTGRADMEDJ-2020-138577</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/POSTGRADMEDJ-2020-138577</ArticleId><ArticleId IdType="pmc">PMC10017004</ArticleId><ArticleId IdType="pubmed">32978337</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastrian-Soto G. (2020). Bases Gen&#xe9;ticas y Moleculares del COVID-19 (SARS-CoV-2). Mecanismos de Patog&#xe9;nesis y de Respuesta Inmune. Int. J. Odontostomatol. 14 331&#x2013;337. 10.4067/s0718-381x2020000300331</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/s0718-381x2020000300331</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A. B., Verma A. (2020). COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: What Is the evidence? JAMA 323 1769&#x2013;1770. 10.1001/JAMA.2020.4812</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2020.4812</ArticleId><ArticleId IdType="pubmed">32208485</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil J., Schwab A., Nussberger J., Schaffner T., Saavedra J. M., Imboden H. (2010). Intraneuronal angiotensinergic system in rat and human dorsal root ganglia. Regul. Pept. 162 90&#x2013;98. 10.1016/j.regpep.2010.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.regpep.2010.03.004</ArticleId><ArticleId IdType="pmc">PMC2928989</ArticleId><ArticleId IdType="pubmed">20346377</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil M. O., Mali Y. S., Patil P. A., Karnavat D. R. (2020). Development of immunotherapeutic nanoparticles for treatment of tuberculosis. Asian J. Pharm. Res. 10:226. 10.5958/2231-5691.2020.00039.8</Citation><ArticleIdList><ArticleId IdType="doi">10.5958/2231-5691.2020.00039.8</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul M., Mehr A. P., Kreutz R. (2006). Physiology of local renin-angiotensin systems. Physiol. Rev. 86 747&#x2013;803. 10.1152/PHYSREV.00036.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/PHYSREV.00036.2005</ArticleId><ArticleId IdType="pubmed">16816138</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H., Li W., Seth D. M., Nair A. R., Francis J., Feng Y. (2013). (Pro)renin receptor mediates both angiotensin II-dependent and -independent oxidative stress in neuronal cells. PLoS One 8:e58339. 10.1371/journal.pone.0058339</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058339</ArticleId><ArticleId IdType="pmc">PMC3597628</ArticleId><ArticleId IdType="pubmed">23516464</ArticleId></ArticleIdList></Reference><Reference><Citation>Poustforoosh A., Nematollahi M. H., Hashemipour H., Pardakhty A. (2022). Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles. J. Control. Release 343 777&#x2013;797. 10.1016/J.JCONREL.2022.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JCONREL.2022.02.015</ArticleId><ArticleId IdType="pubmed">35183653</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinelli F., Trevisan C., Noale M., Franchini M., Giacomelli A., Cori L., et al. (2022). &#x2018;Sex- and gender-related differences linked to SARS-CoV-2 infection among the participants in the web-based EPICOVID19 survey: The hormonal hypothesis&#x2019;. Maturitas 158 61&#x2013;69. 10.1016/J.MATURITAS.2021.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MATURITAS.2021.11.015</ArticleId><ArticleId IdType="pmc">PMC8642247</ArticleId><ArticleId IdType="pubmed">35241240</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucci F., Annoni F., Souza dos Santos R. A., Taccone F. S., Rooman M. (2021). Quantifying renin-angiotensin-system alterations in covid-19. Cells 10:2755. 10.3390/CELLS10102755/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/CELLS10102755/S1</ArticleId><ArticleId IdType="pmc">PMC8535134</ArticleId><ArticleId IdType="pubmed">34685735</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarleri J., Delpino M. V. (2022). SARS-CoV-2 interacts with renin-angiotensin system: Impact on the central nervous system in elderly patients. Geroscience 44 547&#x2013;565. 10.1007/S11357-022-00528-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11357-022-00528-0</ArticleId><ArticleId IdType="pmc">PMC8853071</ArticleId><ArticleId IdType="pubmed">35157210</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E. M., Logsdon A. F., Hansen K. M., Williams L. M., Reed M. J., Baumann K. K., et al. (2020). The S1 protein of SARS-CoV-2 crosses the blood&#x2013;brain barrier in mice. Nat. Neurosci. 24 368&#x2013;378. 10.1038/s41593-020-00771-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas A., Gonzalez I., Morales M. A. (2020). SARS-CoV-2-mediated inflammatory response in lungs: Should we look at RAGE? Inflamm. Res. 69 641&#x2013;643. 10.1007/s00011-020-01353-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01353-x</ArticleId><ArticleId IdType="pmc">PMC7200049</ArticleId><ArticleId IdType="pubmed">32372149</ArticleId></ArticleIdList></Reference><Reference><Citation>Royea J., Martinot P., Hamel E. (2020). Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer&#x2019;s disease. Neurobiol. Dis. 134104644. 10.1016/j.nbd.2019.104644</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104644</ArticleId><ArticleId IdType="pubmed">31669735</ArticleId></ArticleIdList></Reference><Reference><Citation>Rukavina Mikusic N. L., Pineda A. M., Gironacci M. M. (2021). &#x2018;Angiotensin-(1-7) and Mas receptor in the brain&#x2019;, exploration of medicine. Open Explor. 2 268&#x2013;293. 10.37349/EMED.2021.00046</Citation><ArticleIdList><ArticleId IdType="doi">10.37349/EMED.2021.00046</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;ntha P., Veszelka S., Hoyk Z., M&#xe9;sz&#xe1;ros M., Walter F. R., T&#xf3;th A. E., et al. (2016). Restraint stress-induced morphological changes at the blood-brain barrier in adult rats. Front. Mol. Neurosci. 8:88. 10.3389/FNMOL.2015.00088</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNMOL.2015.00088</ArticleId><ArticleId IdType="pmc">PMC4712270</ArticleId><ArticleId IdType="pubmed">26834555</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravi B., Li Z., Lang C. N., Schmid B., Lang F. K., Grad S., et al. (2021). The tissue renin-angiotensin system and its role in the pathogenesis of major human diseases: Quo Vadis? Cells 10 1&#x2013;23. 10.3390/cells10030650</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030650</ArticleId><ArticleId IdType="pmc">PMC7999456</ArticleId><ArticleId IdType="pubmed">33804069</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelling P., Clauser E., Felix D. (1983). &#x2018;Regulation of angiotensinogen in the central nervous system&#x2019;. Clin. Exp. Hypertens. A 5 1047&#x2013;1061. 10.3109/10641968309048841</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10641968309048841</ArticleId><ArticleId IdType="pubmed">6357557</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelling P., Ganten U., Sponer G., Unger T., Ganten D. (1980). &#x2018;Components of the renin-angiotensin system in the cerebrospinal fluid of rats and dogs with special consideration of the origin and the fate of Angiotensin II&#x2019;. Neuroendocrinology 31 297&#x2013;308. 10.1159/000123092</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000123092</ArticleId><ArticleId IdType="pubmed">7003424</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieffer E., Schieffer B. (2022). The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection. J. Renin Angiotensin Aldosterone Syst. 2022 2549063. 10.1155/2022/2549063</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2549063</ArticleId><ArticleId IdType="pmc">PMC9166989</ArticleId><ArticleId IdType="pubmed">35685188</ArticleId></ArticleIdList></Reference><Reference><Citation>Seltzer S. (2020). Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. Int. J. Infect. Dis. 101 42&#x2013;45. 10.1016/J.IJID.2020.09.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2020.09.041</ArticleId><ArticleId IdType="pmc">PMC7497736</ArticleId><ArticleId IdType="pubmed">32950735</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigemoto-Mogami Y., Hoshikawa K. (2018). Activated microglia disrupt the blood-brain barrier and induce chemokines and cytokines in a rat in vitro model. Front. Cell. Neurosci. 12:494. 10.3389/FNCEL.2018.00494</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNCEL.2018.00494</ArticleId><ArticleId IdType="pmc">PMC6300509</ArticleId><ArticleId IdType="pubmed">30618641</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinohara K., Liu X., Morgan D. A., Davis D. R., Sequeira-Lopez M. L. S., Cassell M. D., et al. (2016). Selective deletion of the brain-specific isoform of renin causes neurogenic hypertension. Hypertension 68 1385&#x2013;1392. 10.1161/HYPERTENSIONAHA.116.08242</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.116.08242</ArticleId><ArticleId IdType="pmc">PMC5159235</ArticleId><ArticleId IdType="pubmed">27754863</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva A. C. S., Miranda A. S., Rocha N. P., Teixeira A. L. (2017). Renin angiotensin system in liver diseases: Friend or foe? World J. Gastroenterol. 23 3396&#x2013;3406. 10.3748/WJG.V23.I19.3396</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/WJG.V23.I19.3396</ArticleId><ArticleId IdType="pmc">PMC5442076</ArticleId><ArticleId IdType="pubmed">28596676</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Lu C., Leszek J., Zhang J. (2021). Design and development of nanomaterial-based drug carriers to overcome the blood&#x2013;brain barrier by using different transport mechanisms. Int. J. Mol. Sci. 22:10118. 10.3390/IJMS221810118</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS221810118</ArticleId><ArticleId IdType="pmc">PMC8465340</ArticleId><ArticleId IdType="pubmed">34576281</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriramula S., Xia H., Xu P., Lazartigues E. (2015). Brain-targeted ACE2 overexpression attenuates neurogenic hypertension by inhibiting COX mediated inflammation. Hypertension 65:577. 10.1161/HYPERTENSIONAHA.114.04691</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.114.04691</ArticleId><ArticleId IdType="pmc">PMC4326547</ArticleId><ArticleId IdType="pubmed">25489058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Gao C., Gao D., Sun R., Li W., Wang F., et al. (2021). Reduction in pericyte coverage leads to blood&#x2013;brain barrier dysfunction via endothelial transcytosis following chronic cerebral hypoperfusion. Fluids Barriers CNS 18 1&#x2013;18. 10.1186/S12987-021-00255-2/FIGURES/8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12987-021-00255-2/FIGURES/8</ArticleId><ArticleId IdType="pmc">PMC8101037</ArticleId><ArticleId IdType="pubmed">33952281</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson P. A., McGavern D. B. (2015). Viral diseases of the central nervous system. Curr. Opin. Virol. 11 44&#x2013;54. 10.1016/j.coviro.2014.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.12.009</ArticleId><ArticleId IdType="pmc">PMC4456224</ArticleId><ArticleId IdType="pubmed">25681709</ArticleId></ArticleIdList></Reference><Reference><Citation>Tashev R., Stefanova M. (2015). Hippocampal asymmetry in angiotensin II modulatory effects on learning and memory in rats. Acta Neurobiol. Exp. 75 48&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">25856522</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh I. M., bin Abdulhak A. A., Tlayjeh H., Al-Mallah M. H., Sohail M. R., Hassett L. C., et al. (2022). Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and the risk of SARS-CoV-2 infection or hospitalization with COVID-19 disease: A systematic review and meta-analysis. Am. J. Ther. 29 E74&#x2013;E84. 10.1097/MJT.0000000000001319</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000001319</ArticleId><ArticleId IdType="pubmed">33395057</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsivgoulis G., Palaiodimou L., Zand R., Lioutas V. A., Krogias C., Katsanos A. H., et al. (2020). COVID-19 and cerebrovascular diseases: A comprehensive overview. Ther. Adv. Neurol. Disorders 13 1&#x2013;18. 10.1177/1756286420978004</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286420978004</ArticleId><ArticleId IdType="pmc">PMC7727052</ArticleId><ArticleId IdType="pubmed">33343709</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzun S., Keles A., Okutan D., Yildiran T., Palamar D. (2021). assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with coVid-19. Eur. J. Phys. Rehab. Med. 57 653&#x2013;662. 10.23736/S1973-9087.20.06563-6</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.20.06563-6</ArticleId><ArticleId IdType="pubmed">33393277</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wagoner N. J., Oh J.-W., Repovic P., Benveniste E. N. (1999). Interleukin-6 (IL-6) production by astrocytes: Autocrine regulation by IL-6 and the soluble IL-6 Receptor. J. Neurosci. 19 5236&#x2013;5244. 10.1523/JNEUROSCI.19-13-05236.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-13-05236.1999</ArticleId><ArticleId IdType="pmc">PMC6782316</ArticleId><ArticleId IdType="pubmed">10377335</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas Vargas R. A., Varela Mill&#xe1;n J. M., Fajardo Bonilla E. (2022). Renin&#x2013;angiotensin system: Basic and clinical aspects&#x2014;A general perspective. Endocrinol. Diabet. Nutr (English ed.) 69 52&#x2013;62. 10.1016/j.endien.2022.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.endien.2022.01.005</ArticleId><ArticleId IdType="pmc">PMC8547789</ArticleId><ArticleId IdType="pubmed">34723133</ArticleId></ArticleIdList></Reference><Reference><Citation>Wal P., Wal A., Rai A., Dixit A. (2011). Aliskiren: An orally active renin inhibitor. J. Pharm. Bioallied Sci. 3:189. 10.4103/0975-7406.80764</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0975-7406.80764</ArticleId><ArticleId IdType="pmc">PMC3103912</ArticleId><ArticleId IdType="pubmed">21687346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Gheblawi M., Nikhanj A., Munan M., MacIntyre E., O&#x2019;Neil C., et al. (2022). Dysregulation enzyme)-2 and of renin-angiotensin ACE (Angiotensin-converting peptides in SARS-CoV-2 mediated mortality and end-organ injuries. Hypertension 79, 365&#x2013;378. 10.1161/HYPERTENSIONAHA.121.18295</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.121.18295</ArticleId><ArticleId IdType="pubmed">34844421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q. G., Xue X., Yang Y., Gong P. Y., Jiang T., Zhang Y. D. (2018). Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion. J. Renin-Angiotensin Aldosterone Syst. 19:1470320318799587. 10.1177/1470320318799587</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1470320318799587</ArticleId><ArticleId IdType="pmc">PMC6144503</ArticleId><ArticleId IdType="pubmed">30223703</ArticleId></ArticleIdList></Reference><Reference><Citation>Welser-Alves J. V., Milner R. (2013). Microglia are the major source of TNF-&#x3b1; and TGF-&#x3b2; in postnatal glial cultures; regulation by cytokines, lipopolysaccharide, and vitronectin. Neurochem. Int. 63 47&#x2013;53. 10.1016/J.NEUINT.2013.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEUINT.2013.04.007</ArticleId><ArticleId IdType="pmc">PMC3819935</ArticleId><ArticleId IdType="pubmed">23619393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J. W., Kawas L. H., Harding J. W. (2015). The development of small molecule angiotensin IV analogs to treat Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Prog. Neurobiol. 125 26&#x2013;46. 10.1016/j.pneurobio.2014.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2014.11.004</ArticleId><ArticleId IdType="pubmed">25455861</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H., Sun Q., Yuan S., Wang J., Li F., Gao H., et al. (2022). AT1 Receptors: Their actions from hypertension to cognitive impairment. Cardiovasc. Toxicol. 22 311&#x2013;325. 10.1007/s12012-022-09730-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12012-022-09730-0</ArticleId><ArticleId IdType="pmc">PMC8868040</ArticleId><ArticleId IdType="pubmed">35211833</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X., Zhang C., Ma X., Miao H., Wang J., Liu L., et al. (2015). Angiotensin-(1-7) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2/ROS and PI3K/NO pathways. Exp. Cell Res. 336 58&#x2013;65. 10.1016/J.YEXCR.2015.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.YEXCR.2015.06.010</ArticleId><ArticleId IdType="pmc">PMC4509813</ArticleId><ArticleId IdType="pubmed">26101159</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Sriramula S., Xia H., Moreno-Walton L., Culicchia F., Domenig O., et al. (2017). Clinical relevance and role of neuronal AT 1 Receptors in ADAM17-Mediated ACE2 shedding in neurogenic hypertension. Circ. Res. 121 43&#x2013;55. 10.1161/CIRCRESAHA.116.310509</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.310509</ArticleId><ArticleId IdType="pmc">PMC5507353</ArticleId><ArticleId IdType="pubmed">28512108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D., Chu H., Hou Y., Chai Y., Shuai H., Lee A. C. Y., et al. (2020). Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J. Infect. Dis. 222 734&#x2013;745. 10.1093/INFDIS/JIAA356</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAA356</ArticleId><ArticleId IdType="pmc">PMC7337793</ArticleId><ArticleId IdType="pubmed">32563187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying H., Ebrahimi M., Keivan M., Khoshnam S. E., Salahi S., Farzaneh M. (2021). miRNAs; a novel strategy for the treatment of COVID-19. Cell Biol. 45 2045&#x2013;2053. 10.1002/CBIN.11653</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/CBIN.11653</ArticleId><ArticleId IdType="pmc">PMC8426984</ArticleId><ArticleId IdType="pubmed">34180562</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida T., Galvez S., Tiwari S., Rezk B. M., Semprun-Prieto L., Higashi Y., et al. (2013). Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration. J. Biol. Chem. 288 23823&#x2013;23832. 10.1074/jbc.M112.449074</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.449074</ArticleId><ArticleId IdType="pmc">PMC3745329</ArticleId><ArticleId IdType="pubmed">23831688</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zetter M. A., Guerra E. C., Hern&#xe1;ndez V. S., Mahata S. K., Eiden L. E. (2021). ACE2 in the second act of COVID-19 syndrome: Peptide dysregulation and possible correction with oestrogen. J. Neuroendocrinol. 33:e12935. 10.1111/JNE.12935</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JNE.12935</ArticleId><ArticleId IdType="pmc">PMC7995212</ArticleId><ArticleId IdType="pubmed">33462852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Walker J. B., Minic Z., Liu F., Goshgarian H., Mao G. (2016). Transporter protein and drug-conjugated gold nanoparticles capable of bypassing the blood-brain barrier. Sci. Rep. 6:25794. 10.1038/SREP25794</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/SREP25794</ArticleId><ArticleId IdType="pmc">PMC4867579</ArticleId><ArticleId IdType="pubmed">27180729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J. L., Li G. Z., Chen S. Z., Wang J. J., Olson J. E., Xia H. J., et al. (2014). Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence. CNS Neurosci. Ther. 20 452&#x2013;459. 10.1111/cns.12233</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12233</ArticleId><ArticleId IdType="pmc">PMC4840841</ArticleId><ArticleId IdType="pubmed">24581232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J., Wang Y., Li K., Meyerholz D. K., Allamargot C., Perlman S. (2021). Severe acute respiratory syndrome coronavirus 2-Induced immune activation and death of monocyte-derived human macrophages and dendritic cells. J. Infect. Dis. 223 785&#x2013;795. 10.1093/INFDIS/JIAA753</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAA753</ArticleId><ArticleId IdType="pmc">PMC7799009</ArticleId><ArticleId IdType="pubmed">33277988</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Krishnan N., Jiang Y., Fang R. H., Zhang L. (2021). Nanotechnology for virus treatment. Nano Today 36:101031. 10.1016/J.NANTOD.2020.101031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NANTOD.2020.101031</ArticleId><ArticleId IdType="pmc">PMC7836394</ArticleId><ArticleId IdType="pubmed">33519948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Zhang M., Wang J., Gao J. (2020). Sars-Cov-2: Underestimated damage to nervous system. Travel Med. Infect. Dis. 36:101642. 10.1016/J.TMAID.2020.101642</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TMAID.2020.101642</ArticleId><ArticleId IdType="pmc">PMC7269702</ArticleId><ArticleId IdType="pubmed">32220634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair A. S., McAlpine L. S., Gardin T., Farhadian S., Kuruvilla D. E., Spudich S. (2020). Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus Disease 2019: A REvIEW. JAMA Neurology 77 1018&#x2013;1027. 10.1001/JAMANEUROL.2020.2065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANEUROL.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>